Raghu Kalluri

📣Coming Soon: Extracellular Vesicles and Exosomes Biology Core Facility (EVcore) A first of its kind facility to support your EV research needs including isolation, characterization, imaging, engineering and more. Grateful to @CPRITTexas for supporting this resource. Stay…

Congratulations @RonDePinho, recipient of the 2025 AACR-Princess Takamatsu Memorial Lectureship. Ron’s impact on the field is immense, and we are deeply proud to have him represent the Department of Cancer Biology at @MDAndersonNews. His lecture was a show-stopper, and a true…

Great highlight of NCI-funded Research Advances in Cancer Biology. Honored to have the work of @KalluriLab at @MDAndersonNews included among this list of important discoveries from 2024.

A heartwarming surprise from my family. Every badge since my early career meetings and invited lectures to present day. Tossed into a box over the years, they have been transformed into this work of art as a reminder to me. 30 years of sharing the innovation and discovery by…

What a delight to hear @JoyaChandraPhD talk for today’s Cancer Biology Seminar Series. Fun fact: Joya trained in our department as a graduate student, earning her PhD from @MDA_UTHGrad in 1998. Today, she returned as our invited speaker. Welcome back, Professor Chandra!

Had the honor of hosting @Aiims1742 for his induction into the Association of American Physicians. A friend, colleague and collaborator extraordinaire, Anirban is The Man, and is most deserving of this recognition (I should be 👉🏽 at him). @nyulangone is getting a good one, and we…

A true “farm to table” effort at @MDAndersonNews funded by our #PancreaticCancer Moonshot. The 1st clinical trial of systemic exosomes targeting mutant KRAS in metastatic pancreatic cancer. Five years from @rkalluriMDPhD discovery to patients. No DLTs whatsoever to speak of.

New preprint by @mcandrews_kate (previously @KalluriLab, now PI at @MDAndersonNews): CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRASG12D inhibition in #PancreaticCancer In this preclinical study, Kate demonstrates that while acute…

Comprehensive review by @KalluriLab of natural and engineered EVs in cancer diagnosis and therapy. The authors highlight EV engineering strategies poised to dramatically expand the use of EV-based platforms in oncologic settings. Read it here 🔗 go.acs.org/ceD

This afternoon, UTMB hosted an excellent research and clinical symposium focused on kidney science and care including all aspects of Nephrology. Thank you to our presenters @farhaddanesh123, Chief of Nephrology at MD Anderson Cancer Center; @rkalluriMDPhD, Professor and Chairman…

Delighted to host my friend and esteemed colleague, Doug Hanahan, for the Stadtler Endowed Distinguished Lecture. “Thirty + years of dissecting multifaceted barriers to anti-tumor immunity” What a treat for our trainees!

Thanks to our keynote panelists at yesterday's event for the Cancer Moonshot, @DCarnival46, @rkalluriMDPhD, and @JohnLFlavin. It was a fantastic group with an invigorating discussion, and thanks to @TreedinDC for moderating!

Super proud of my talented mentees @Bingruilii and @tejassaboo for their first place win at MIT Policy Hackathon! 🏆 Great job, guys!